Retour aux appels d'offres

Produits pharmaceutiques (11802)

Ouvert
Date limite
6 jours restants
Mars 09, 2026
Détails du contrat
Catégorie
Autre
Référence
6595920
Valeur
Non divulgué
Lieu
Vilnius County, Lituanie
Publié
Février 23, 2026
Code CPV
Calendrier du projet

Publication de l'appel d'offres

Février 19, 2026

Date limite pour les questions

Mars 02, 2026

Date limite de soumission

Mars 09, 2026

Ouverture de l'appel d'offres

Mars 09, 2026

Probabilité de gainPRO
🔒
Passer au Professionnel
Consultez votre probabilité de gain estimée basée sur les données historiques.
Passer au Professionnel →
Aperçu du secteurPRO
🔒
Débloquer les aperçus du secteur
Consultez les prix gagnants moyens, les niveaux de concurrence et les tendances du marché.
Passer au Professionnel →
Budget
Non divulgué
Durée
38 mois
Lieu
Vilnius County
Type
Autre
67
Score de qualité/100
Bon
Référentiel de marché
Prix moyen gagnant
€50,148
Offres moyennes
7.2
Concurrence
Élevée
PME gagnantes
99%
54,649 appels d'offres analysés

Description originale de l'appel d'offres

L'autorité contractante a l'intention d'acquérir des produits pharmaceutiques. Voir la description dans les documents de marché.

Analyse des risques

Veuillez vous connecter pour utiliser l'analyse des risques.

Se connecter

Stratégie gagnante

Connectez-vous pour accéder aux recommandations de stratégie gagnante.

Se connecter

Concurrents

Passez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.

Se connecter

Exigences et qualifications

1 exigences dans 1 catégories

Soumission (1)
SUBMISSION REQUIREMENTS1
--Bids must be submitted by 2026-03-09 09:00:00.

Aperçu des exigences

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Documents

9 documents disponibles avec des résumés IA

Bendrosios pirkimo sąlygosDOC
BPS_SAK.docx

This document contains the general procurement conditions for a simplified open tender organized by VšĮ Vilniaus universiteto ligoninė Santaros klinikos, outlining legal bases, procurement object details, and supplier qualification requirements.

SPS 2 priedas_Prekių pirkimo pardavimo sutarties projektasDOC
SPS 2 priedas_Prekiu pirkimo pardavimo sutart...

This document contains the general and special conditions, definitions, and interpretation rules for a draft goods purchase and sale contract.

SPS 4 priedas_Pasiūlymo formaDOC
SPS 4 priedas_Pasiulymo forma.docx

This document contains a tender offer form for medicinal products, requiring the bidder to confirm agreement with procurement conditions, detail proposed goods and prices, list subcontractors, and declare any confidential information.

Specialiosios pirkimo sąlygosDOC
SPS_SAK.docx

This document contains the special procurement conditions for Vilnius University Hospital Santaros Clinics' simplified open tender for medicinal products, including details on the procurement object, qualification requirements, award criteria (lowest price), and required submission documents.

espd-request.pdfPDF
espd-request.pdf -- 77.3 KB

No content extracted

NoticePDF
Notice_6595920.pdf

This document contains a tender notice from VšĮ Vilniaus universiteto ligoninė Santaros klinikos in Lithuania for the open procurement of pharmaceutical products, specifically Sodium Chloride and Probenecid, with a submission deadline of March 9, 2026.

README.txtTXT
README.txt -- 835 B

This document is a binary file, despite its .txt extension, which appears to be an archive containing an ESPD (European Single Procurement Document) request in both XML and PDF formats.

SPS 1 priedas_Techninė specifikacijaXLS
SPS 1 priedas_Technine specifikacija.xlsx

This document contains the technical specifications for the procurement of medicinal products, including general requirements, issued by VšĮ Vilniaus universiteto ligoninė Santaros klinikos.

espd-request.xmlXML
espd-request.xml -- 97.9 KB

This document contains an ESPD (European Single Procurement Document) request, which is a standard form for bidders to declare their compliance with exclusion and selection criteria in a public procurement procedure.

Aperçu des documents

Inscrivez-vous pour consulter les résumés et l'analyse des documents

67
Bon

Score de qualité de l'appel d'offres

This tender for pharmaceutical products is generally well-structured with comprehensive documents and an EU-compliant procedure. However, the lack of disclosed estimated value and, critically, the absence of specified evaluation criteria significantly impact its transparency and fairness.

Répartition du score

Conformité légale75/100

The tender defines an open procedure under EU Directive 2014/24/ES and uses appropriate CPV codes. The use of ESPD indicates compliance with EU standards. However, the estimated value is not disclosed, and the reveal date is missing, which are minor transparency issues.

Estimated value not disclosed
Missing tender reveal date
Clarté60/100

While the description refers to detailed documents like technical specifications and a draft contract, the AI-extracted requirements are high-level. Crucially, the absence of specified evaluation criteria in the provided summary is a significant clarity concern, making it difficult for bidders to understand how offers will be judged.

No evaluation criteria specified in the summary
AI-extracted requirements are high-level, referring to documents for details
Exhaustivité70/100

The tender includes all basic information, deadlines, and duration, and provides a comprehensive set of documents. However, the estimated value is not disclosed, and the evaluation criteria are not explicitly defined in the provided summary, which are notable gaps.

Estimated value not disclosed
Evaluation criteria not explicitly defined in the summary
Équité60/100

Full document access and e-procurement support contribute to fairness. However, the undisclosed estimated value and, more significantly, the absence of specified evaluation criteria are major concerns, as they can undermine transparency and objectivity in the selection process.

Estimated value not disclosed
No evaluation criteria specified
Aspect pratique75/100

The tender supports e-procurement and clearly specifies the contract duration. The provision of an offer form is also practical. However, the contract start date is not explicitly known, and financing information is limited due to the undisclosed value.

Contract start date not explicitly known
Limited financing information due to undisclosed value
Cohérence des données85/100

Key dates are logical and consistent, and there are no reported disputes or suspensions. Most key fields are populated, though the estimated value is not disclosed, and the liable person field is empty, representing minor data gaps.

Estimated value not disclosed
Liable person field is empty
Durabilité20/100

There is no explicit mention of green procurement, social aspects, or innovation focus within the provided tender information. This indicates a lack of integration of sustainability criteria.

No explicit green procurement criteria
No social aspects mentioned

Points forts

Clear procedure type (Open, EU Directive 2014/24/ES)
Comprehensive set of tender documents available, including technical specifications and draft contract
Use of European Single Procurement Document (ESPD)
E-Procurement enabled for submission
Specific and appropriate CPV code provided

Préoccupations

Estimated value is not disclosed, limiting transparency for bidders
Evaluation criteria are not specified in the provided summary, raising significant fairness and clarity issues
Missing the tender's reveal date
No explicit mention of green, social, or innovation aspects in the tender

Recommandations

1. Ensure evaluation criteria are clearly defined, easily accessible, and explicitly stated within the tender documents to enhance transparency and fairness.
2. Disclose the estimated value of the contract to allow potential bidders to better assess the opportunity and prepare their offers.
3. Explicitly state the tender reveal date for full transparency and to ensure all legal disclosure requirements are met.

Aperçu de la notation IA

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Analyse complète du score de qualité
Répartition détaillée des sous-scores
Aperçu des forces et des préoccupations
Recommandations stratégiques

Aucune carte de crédit requise • Configuration en 2 minutes

Ajouter au Pipeline